Actually, that was an 'exploratory' end point as per their presentation
Primary:
Safety and tolerability
Secondary:
• Characterize PK/PD*
parameters
Exploratory:
• Physical and visual skin and
scar assessments
So contrary to what is being said here by some posters, they did meet the end points!
Actually, that was an 'exploratory' end point as per their...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.65M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 519110 | 2.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 131428 | 2 |
View Market Depth
| Last trade - 10.39am 03/07/2024 (20 minute delay) ? |
| SNT (ASX) Chart |
Day chart unavailable